Anti-Zpkp1 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project
(www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry.
The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these
protocols and other useful information about Prestige Antibodies and the HPA, visit .
Allgemeine Beschreibung
MAP3K12 (mitogen-activated protein kinase kinase kinase 12) belongs to the serine/threonine protein kinase family. It is also known as DLK (dual leucine zipper kinase). MAP3K12 is located on human chromosome 12q13.
Biochem/physiol Actions
MAP3K12 (mitogen-activated protein kinase kinase kinase 12) participates in development, cell differentiation, apoptosis and neuronal response to injury. DLK (dual leucine zipper kinase) serves as an upstream activator of the mitogen-activated protein kinase (MAPK) pathways. It may be essential for proliferation of cells. MAP3K12 is involved in the growth of neurons and helps in axon regeneration. It also participates in the pathogenesis of neurodegenerative disease and diabetes mellitus.
Anti-Zpkp1 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
